Silexion Therapeutics Corp

NasdaqGM:SLXN Stock Report

Market Cap: US$2.8m

Silexion Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SLXN?
Owner TypeNumber of SharesOwnership Percentage
Institutions125,4331.51%
Hedge Funds1,020,85212.3%
General Public7,168,73986.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 114.9%.


Top Shareholders

Top 5 shareholders own 13.79% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.3%
Wildcat Capital Management, LLC
1,020,852US$340.0k0%0.08%
1.08%
Hudson River Trading LLC, Asset Management Arm
89,970US$30.0k0%no data
0.18%
Two Sigma Securities, LLC, Asset Management Arm
15,120US$5.0k0%no data
0.18%
UBS Asset Management AG
15,059US$5.0k0%no data
0.064%
Geode Capital Management, LLC
5,284US$1.8k0%no data